Abstract
Background It is difficult to differentiate early compensated cirrhosis from chronic hepatitis solely by clinical features. The aim of this study was to assess the usefulness of liver stiffness measurement (LSM) for detection of early compensated liver cirrhosis in chronic hepatitis B (CHB). Methods Ninety-one consecutive CHB patients who underwent liver biopsy (LB) and LSM were recruited. All patients did not fulfill the clinical criteria for cirrhosis. The cutoff of LSM for cirrhosis was 10.3 kPa. Results All patients were divided into either group A (cirrhosis) or group B (CHB) according to LB result. The median LSM values of groups A and B were 11.8 and 7.6 kPa, respectively (P < 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of LSM in predicting cirrhosis were 0.59, 0.78, 0.68, and 0.72, respectively. The area under the receiver operating characteristics curve (AUROC) of LSM was 0.803, whereas the AUROCs of aspartate to alanine aminotransferase ratio (AAR) and aspartate aminotransferase to platelet ratio index (APRI) were 0.488 and 0.723, respectively. Conclusions LSM showed an acceptable diagnostic accuracy for detecting early compensated cirrhosis in CHB.
Similar content being viewed by others
References
Craxi A, Antonucci G, Camma C. Treatment options in HBV. J Hepatol. 2006;44:S77–S83. doi:10.1016/j.jhep.2005.11.018.
Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–1531. doi:10.1056/NEJMoa033364.
Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500. doi:10.1056/NEJM200102153440706.
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32:477–481. doi:10.1053/jhep.2000.16602.
Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350. doi:10.1053/j.gastro.2004.11.018.
Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54. doi:10.1002/hep.20506.
Marcellin P, de Ledinghen V, Dhumeaux D, et al. Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan. Hepatology. 2005;42:715A. abstract.
Imperiale TF, Said AT, Cummings OW, Born LJ. Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Am J Gastroenterol. 2000;95:2328–2332. doi:10.1111/j.1572-0241.2000.02322.x.
Lackner C, Struber G, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376–1382. doi:10.1002/hep.20717.
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C: The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–293. doi:10.1002/hep.510240201.
Fattovich G. Natural history of hepatitis B. In: EASL International Consensus Conference on Hepatitis B 2002, Gene`ve; 2002, 47–62.
Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463–472. doi:10.1053/gast.1997.v112.pm9024300.
Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death. Gut. 2000;47:131–136. doi:10.1136/gut.47.1.131.
Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut. 2004;53:744–749. doi:10.1136/gut.2003.020263.
Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut. 2005;55:403–408. doi:10.1136/gut.2005.069153.
Kim BK, Kim SA, Park YN, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969–976. doi:10.1111/j.1478-3231.2007.01519.x.
Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457.
Acknowledgments
This study was supported by the grant of the Good Health R & D Project from the Ministry of Health and Welfare, Republic of Korea (A050021), and in part by a grant from Brain Korea 21 Project for Medical Science.
Author information
Authors and Affiliations
Corresponding author
Additional information
Do Young Kim and Seung Up Kim have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kim, D.Y., Kim, S.U., Ahn, S.H. et al. Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B. Dig Dis Sci 54, 1758–1763 (2009). https://doi.org/10.1007/s10620-008-0541-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0541-2